Mah Douglas Y, Cheng Henry, Alexander Mark E, Sleeper Lynn, Newburger Jane W, Del Nido Pedro J, Thiagarajan Ravi R, Rajagopal Satish K
Department of Cardiology, Boston Children's Hospital and Harvard Medical School, Boston, Mass.
Department of Cardiology, Boston Children's Hospital and Harvard Medical School, Boston, Mass.
J Thorac Cardiovasc Surg. 2016 Jul;152(1):189-94. doi: 10.1016/j.jtcvs.2016.03.074. Epub 2016 Apr 11.
Publicly available data from the Pediatric Heart Network's Single Ventricle Reconstruction Trial was analyzed to determine the prevalence, timing, risk factors for, and impact of second- and third-degree heart block (HB) on outcomes in patients who underwent stage 1 palliation (S1P) for hypoplastic left heart syndrome (HLHS).
The presence and date of onset of post-S1P HB occurring within the first year of life, potential risk factors for HB, and factors known to predict poor outcomes after S1P were extracted. Multivariable logistic and Cox regression analyses were performed to identify risk factors for HB and to determine the effect of HB on 3-year transplantation-free survival.
Among the 549 patients in the cohort, 33 (6%) developed HB after S1P. The median interval between S1P and HB was 8 days (interquartile range, 0-133 days). Regression analysis showed that tricuspid valve repair during S1P and obstruction of pulmonary venous drainage requiring pre-S1P intervention were independently associated with HB (adjusted odds ratio [aOR], 11.6, 95% confidence interval [CI] 3.3-40; P < .001 and aOR, 5.1; 95% CI, 1.3-20.6; P = .02, respectively). Transplantation-free survival at 3 years was lower for those with HB (39% vs 65%; P = .004). HB remained associated with transplantation-free survival after controlling for known risk factors (adjusted hazard ratio, 3.1; 95% CI, 1.9-5.0; P < .001). Nine children (27%) had a pacemaker implanted, and 7 of these children (78%) died or underwent heart transplantation.
HB after S1P is rare but heralds a poor outcome. Careful monitoring of these patients is recommended given their significantly increased risks of death and heart transplantation.
分析来自儿科心脏网络单心室重建试验的公开数据,以确定二度和三度心脏传导阻滞(HB)在接受一期姑息性手术(S1P)治疗左心发育不全综合征(HLHS)患者中的患病率、发生时间、危险因素及其对预后的影响。
提取出生后第一年内发生的S1P后HB的存在情况和发病日期、HB的潜在危险因素以及已知可预测S1P后不良预后的因素。进行多变量逻辑回归和Cox回归分析,以确定HB的危险因素,并确定HB对3年无移植生存率的影响。
该队列中的549例患者中,33例(6%)在S1P后发生HB。S1P与HB之间的中位间隔时间为8天(四分位间距,0 - 133天)。回归分析显示,S1P期间的三尖瓣修复以及需要在S1P前进行干预的肺静脉引流梗阻与HB独立相关(校正比值比[aOR]分别为11.6,95%置信区间[CI] 3.3 - 40;P <.001和aOR为5.1;95% CI,1.3 - 20.6;P = 0.02)。发生HB的患者3年无移植生存率较低(39%对65%;P = 0.004)。在控制已知危险因素后,HB仍与无移植生存率相关(校正风险比,3.1;95% CI,1.9 - 5.0;P <.001)。9名儿童(27%)植入了起搏器,其中7名儿童(78%)死亡或接受了心脏移植。
S1P后HB罕见,但预示着不良预后。鉴于这些患者死亡和心脏移植风险显著增加,建议对其进行密切监测。